Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Transcatheter device intervention is now offered as first line therapy for many congenital heart defects (CHD) which were traditionally treated with cardiac surgery. While off-label use of devices is common and appropriate, a growing number of devices are now specifically designed and approved for use in CHD. Advanced imaging is now an integral part of interventional procedures including pre-procedure planning, intra-procedural guidance, and post-procedure monitoring. There is robust societal and industrial support for research and development of CHD-specific devices, and the regulatory framework at the national and international level is patient friendly. It is against this backdrop that we review transcatheter implantable devices for CHD, the role and integration of advanced imaging, and explore the current regulatory framework for device approval.

Original languageEnglish (US)
Article number497
Issue number4
StatePublished - Apr 2022


  • Septal Occluders
  • congenital heart disease
  • cross-sectional imaging
  • stents
  • transcatheter intervention
  • transcatheter pulmonary valve implantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease'. Together they form a unique fingerprint.

Cite this